Detection of Serum Anti-p53 Antibodies from Patients with Ovarian Cancer in China: Correlation to Clinical Parameters

By Qiu Tian   Yang Qiong   Li Xing-rong   Yang Hua   Qiu Lin-lin   Wang Li  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 563-568

Informa Healthcare

Access to resources Recommend Favorite

Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer

By Hao Xiao-Dan   Yang Yue   Song Xin   Zhao Xue-Ke   Wang Li-Dong   He Jun-Dong   Kong Qing-Peng   Tang Nelson Leung Sang   Zhang Ya-Ping  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 226-236

Spandidos Publications

Access to resources Recommend Favorite

Early Detection of Familial Ovarian Cancer

By Dorum A.   Kristensen G.B.   Abeler V.M.   Trope C.G.   Moller P.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1645-1651

Elsevier

Access to resources Recommend Favorite

Poor Correlation with Loss of Heterozygosity on Chromosome 17p and p53 Mutations in Ovarian Cancers

By Sakamoto T.   Nomura N.   Mori H.   Wake N.  

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 173-179

Academic Press

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite